Literature DB >> 23798533

The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cells.

Edwin Garzón1, Philippe Holzmuller, Rachel Bras-Gonçalves, Philippe Vincendeau, Gérard Cuny, Jean Loup Lemesre, Anne Geiger.   

Abstract

Trypanosoma brucei gambiense, a parasitic protozoan belonging to kinetoplastids, is the main etiological agent of human African trypanosomiasis (HAT), or sleeping sickness. One major characteristic of this disease is the dysregulation of the host immune system. The present study demonstrates that the secretome (excreted-secreted proteins) of T. b. gambiense impairs the lipopolysaccharide (LPS)-induced maturation of murine dendritic cells (DCs). The upregulation of major histocompatibility complex class II, CD40, CD80, and CD86 molecules, as well as the secretion of cytokines such as tumor necrosis factor alpha, interleukin-10 (IL-10), and IL-6, which are normally released at high levels by LPS-stimulated DCs, is significantly reduced when these cells are cultured in the presence of the T. b. gambiense secretome. Moreover, the inhibition of DC maturation results in the loss of their allostimulatory capacity, leading to a dramatic decrease in Th1/Th2 cytokine production by cocultured lymphocytes. These results provide new insights into a novel efficient immunosuppressive mechanism directly involving the alteration of DC function which might be used by T. b. gambiense to interfere with the host immune responses in HAT and promote the infectious process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23798533      PMCID: PMC3754197          DOI: 10.1128/IAI.00125-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

Review 1.  Immunology and immunopathology of African trypanosomiasis.

Authors:  Philippe Vincendeau; Bernard Bouteille
Journal:  An Acad Bras Cienc       Date:  2006-12       Impact factor: 1.753

2.  First isolation of Enterobacter, Enterococcus, and Acinetobacter spp. as inhabitants of the tsetse fly (Glossina palpalis palpalis) midgut.

Authors:  Anne Geiger; Marie-Laure Fardeau; Pascal Grebaut; Gedeao Vatunga; Théophile Josénando; Stéphane Herder; Gérard Cuny; Philippe Truc; Bernard Ollivier
Journal:  Infect Genet Evol       Date:  2009-09-30       Impact factor: 3.342

3.  Serum proteins, blood and plasma volumes in experimental Trypanosoma vivax infections of sheep and goats.

Authors:  V O Anosa; T T Isoun
Journal:  Trop Anim Health Prod       Date:  1976-02       Impact factor: 1.559

4.  Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections.

Authors:  S Magez; M Radwanska; A Beschin; K Sekikawa; P De Baetselier
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression.

Authors:  A Darji; A Beschin; M Sileghem; H Heremans; L Brys; P De Baetselier
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.

Authors:  Tom Bosschaerts; Martin Guilliams; Benoît Stijlemans; Yannick Morias; Daniel Engel; Frank Tacke; Michel Hérin; Patrick De Baetselier; Alain Beschin
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

7.  Rhipicephalus microplus salivary gland molecules induce differential CD86 expression in murine macrophages.

Authors:  Danett K Brake; Stephen K Wikel; Jason P Tidwell; Adalberto A Pérez de León
Journal:  Parasit Vectors       Date:  2010-11-05       Impact factor: 3.876

8.  Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.

Authors:  Gerardo Priotto; Loretxu Pinoges; Isaac Badi Fursa; Barbara Burke; Nathalie Nicolay; Guillaume Grillet; Cathy Hewison; Manica Balasegaram
Journal:  BMJ       Date:  2008-03-05

9.  Saliva of the Yellow Fever mosquito, Aedes aegypti, modulates murine lymphocyte function.

Authors:  H A Wasserman; S Singh; D E Champagne
Journal:  Parasite Immunol       Date:  2004 Jun-Jul       Impact factor: 2.280

10.  T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis.

Authors:  Viki Bockstal; Patrick Guirnalda; Guy Caljon; Radhika Goenka; Janice C Telfer; Deborah Frenkel; Magdalena Radwanska; Stefan Magez; Samuel J Black
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823

View more
  6 in total

Review 1.  Dealing with environmental challenges: mechanisms of adaptation in Trypanosoma cruzi.

Authors:  Veronica Jimenez
Journal:  Res Microbiol       Date:  2014-02-06       Impact factor: 3.992

2.  Trypanosoma brucei metabolite indolepyruvate decreases HIF-1α and glycolysis in macrophages as a mechanism of innate immune evasion.

Authors:  Anne F McGettrick; Sarah E Corcoran; Paul J G Barry; Jennifer McFarland; Cécile Crès; Anne M Curtis; Edward Franklin; Sinéad C Corr; K Hun Mok; Eoin P Cummins; Cormac T Taylor; Luke A J O'Neill; Derek P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-15       Impact factor: 11.205

Review 3.  Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids.

Authors:  Anne Geiger; Géraldine Bossard; Denis Sereno; Joana Pissarra; Jean-Loup Lemesre; Philippe Vincendeau; Philippe Holzmuller
Journal:  Front Immunol       Date:  2016-05-31       Impact factor: 7.561

Review 4.  Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages?

Authors:  Philippe Holzmuller; Anne Geiger; Romaric Nzoumbou-Boko; Joana Pissarra; Sarra Hamrouni; Valérie Rodrigues; Frédéric-Antoine Dauchy; Jean-Loup Lemesre; Philippe Vincendeau; Rachel Bras-Gonçalves
Journal:  Front Immunol       Date:  2018-04-20       Impact factor: 7.561

5.  Trypanosoma brucei Secreted Aromatic Ketoacids Activate the Nrf2/HO-1 Pathway and Suppress Pro-inflammatory Responses in Primary Murine Glia and Macrophages.

Authors:  Nicole K Campbell; David G Williams; Hannah K Fitzgerald; Paul J Barry; Clare C Cunningham; Derek P Nolan; Aisling Dunne
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

6.  The Trypanosoma brucei-Derived Ketoacids, Indole Pyruvate and Hydroxyphenylpyruvate, Induce HO-1 Expression and Suppress Inflammatory Responses in Human Dendritic Cells.

Authors:  Hannah K Fitzgerald; Sinead A O'Rourke; Eva Desmond; Nuno G B Neto; Michael G Monaghan; Miriam Tosetto; Jayne Doherty; Elizabeth J Ryan; Glen A Doherty; Derek P Nolan; Jean M Fletcher; Aisling Dunne
Journal:  Antioxidants (Basel)       Date:  2022-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.